Pharmacokinetics and pharmacodynamics of nasally delivered midazolam

AIMS: To investigate the pharmacokinetics and pharmacodynamics of nasal formulations containing midazolam (5–30 mg ml(−1)) complexed with cyclodextrin. METHODS: An open-label sequential trial was conducted in eight healthy subjects receiving single doses of 1 mg and 3 mg intranasally and 1 mg midazo...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Haschke, Manuel, Suter, Katja, Hofmann, Sarah, Witschi, Robert, Fröhlich, Johannes, Imanidis, Georgios, Drewe, Jürgen, Briellmann, Thomas A, Dussy, Franz E, Krähenbühl, Stephan, Surber, Christian
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2010
Teme:
Pharmacodynamics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2883753/
https://ncbi.nlm.nih.gov/pubmed/20565452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2010.03611.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items